We can say that yes, Epstein, Gates & co. did "pull off" the pandemic in the end, and in the process awakened millions of people to the corrupt entity that is modern "medicine", and the "elites" behind it, and the ruthless way in which they consider the lives of the masses dispensable to their logic of power, profit & control.

📱 ROBINMG

Part II is live.

⚠️Inside Project Molecule: How JPMorgan and Elite Finance Turned Biology into Infrastructure

Part I exposed the documents.
Part II examines the architecture behind them — how pandemic preparedness quietly evolved into a financialized governance system, with JPMorgan at the center and biology treated as infrastructure long before COVID.

This isn’t about scandal.
It’s about systems.

📖Read Part II:
https://sayerji.substack.com/p/inside-project-molecule-how-jpmorgan

📖 Read Part I (if you missed it):
https://sayerji.substack.com/p/breaking-the-epstein-files-illuminate

🧵 Part I X Thread:
https://x.com/sayerjigmi/status/2018374717426503946
🧵 Part II X Thread:
https://x.com/sayerjigmi/status/2018836140166365450?s=20

MHRA approves zapomeran (Kostaive) mRNA COVID-19 vaccine

https://www.gov.uk/government/news/mhra-approves-zapomeran-kostaive-mrna-covid-19-vaccine

"The Medicines and Healthcare products Regulatory Agency (MHRA) has today, 2 January 2026, approved zapomeran (Kostaive) mRNA COVID-19 vaccine, for the immunisation of individuals aged 18 years of age and older. 
Zapomeran is given as a single 0.5 mL booster dose by injection into the muscle of the upper arm. It contains a self-amplifying messenger RNA (sa-mRNA) which instructs the body’s cells to temporarily make the SARS-CoV-2 spike protein. This teaches the immune system to fight off the virus in the future.  
Julian Beach, Interim Executive Director of Healthcare Quality and Access at the MHRA, said:

Patient safety is our top priority. 
The approval of zapomeran (Kostaive) provides an alternative vaccine for use in adults to prevent COVID-19 caused by SARS-CoV-2.  
As with all licensed medicines, we will continue to monitor its safety closely as it becomes more widely used.

Very common side effects (which may affect more than 1 in 10 people) include pain or tenderness at the injection site, tiredness, chills, fever, muscle and joint pain, headache and dizziness. Most side effects are mild and disappear within a few days of vaccination.  
A full list of side effects can be found in the Patient Information Leaflet (PIL) or the Summary of Product Characteristics (SmPC), which will be published on the MHRA website within 7 days of approval. 
As with any medicine, the MHRA will keep the safety and effectiveness of zapomeran under close review. Anyone who suspects they are having a side effect from this medicine is encouraged to talk to their doctor, pharmacist or nurse and report it directly to the MHRA Yellow Card scheme, either through the website (https://yellowcard.mhra.gov.uk) or by searching the Google Play or Apple App stores for MHRA Yellow Card."

https://www.gov.uk/government/news/mhra-approves-zapomeran-kostaive-mrna-covid-19-vaccine

📱 ROBINMG

The Heart of the Matter: Cardiac Risks of Covid-19 Vaccines ⋆ Brownstone Institute Michael Tomlinson

"Although pro-vaccine papers sometimes have sophisticated technical values, they show little capability for strategic thinking.
Which is the preferable and lowest-risk strategy over the timeframe of the pandemic crisis:

- Undergoing multiple vaccinations of short-term effectiveness

- Minimizing exposure to the spike vaccine?

The scientific literature simply does not test this strategic comparison by comparing overall outcomes for the vaccinated from the point of vaccination to the end of the pandemic crisis period, compared with the truly unvaccinated. But what we do know from the Ip population-level study of England is that Dose 1 for the two most commonly used vaccines increased 11 out of 11 cardiac events and a booster increased both arterial and venous events again for the Pfizer vaccine."

https://brownstone.org/articles/the-heart-of-the-matter-cardiac-risks-of-covid-19-vaccines/

📱 ROBINMG

Moderna CEO Stephane Bancel said the company doesn’t plan to invest in new late-stage vaccine trials because of growing opposition to immunizations from US officials bloom.bg/3LNHufg

📱 ROBINMG